维普中文期刊产品整合服务
82篇 您的检索式:作者名="Gluud LL"
    题名 作者 年代 出处 被引量
1Banding ligation versus beta - blockers as primary prophylaxis in esophageal varices : systematic review of randomized trials 显示文摘Gluud LL Klingenberg S Nikolova D 2007Am J Gastroenterol2007,102,12:1
2Vitamin D supple-ment for prevention of mortality in adults显示文摘Bjelakovic G Gluud LL Nikolova D 2014Cochrane Data-base Sys Rev2014,10,00:1
3Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses显示文摘 Villumsen J Gluud C 2001Ann Intern Med2001,135,11:1
4Mortality in randomized trials of antioxiDant supplements for primary and secondary prevention:Systematic review and metanalysis显示文摘Bjelakovic G Nikolova D Gluud LL 2007JAMA2007,297,:1
5Ribavirin plus interferon versus interferon for chronic hepatitis C显示文摘Brok J Gluud LL Gluud C 2010Cochrane Database Syst Rev2010,20,1:1
6Benzodiazepine receptor antagonists for hepatic encephalopathy显示文摘Als-Nielsen B Gluud LL Gluud C 2004Cochrane Database Syst Rev2004,,00:1
7Systematic review with meta- analyses of studies on the association between cirrhosis and liver metastases显示文摘DaM E Rumessen J Gluud LL 2011Hepatol Res2011,41,7:1
8Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices:systematic review of randomized trials显示文摘Gluud LL Klingenberg S Nikolova D 0,,12:1
9Vitamin D supplementation for prevention of cancer in adults显示文摘Bjelakovie G Gluud LL Nikolova D 2014Cochrane Database Syst Rev2014,6,00:1
10Meta - analysis: the safety and efficacy of vaptans ( tolvaptan, satavaptan and lix-ivaptan) in cirrhosis with ascites or hyponatraemia 显示文摘Dahl E Gluud LL Kimer N 2012Ali- ment Pharmacol Ther2012,36,7:1
11Vitamin D supplementation for prevention of cancer in adults显示文摘Bjelakovic G Gluud LL Nikolova D 2014The Cochrane database of systematic reviews2014,6,00:1
12Antioxidant supplements for liver diseases显示文摘Bjelakovic G Gluud LL Nikolova D 2011Cochrane Database Syst Rev2011,16,00:1
13Mortality in randomized trials of antioxidant supplements for primary and secondaty prevention显示文摘Bjelakovic G Nikolova D Gluud LL 2007JAMA2007,297,8:1
14Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses显示文摘Kjacrgard LL Villumsen J Gluud C 2001Ann inten Med2001,135,11:1
15Empirical evi- dence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta- epidemiological study显示文摘Wood L Egger M Gluud LL 2008BMJ2008,336,7644:1
16Benzodiazepine receptor antagonists for hepatic encephalopathy 显示文摘Als-NieIsen B Gluud LL Gluud C 2004Cochrane Database Syst Rev2004,,00:1
17Effects of adding ribavirin to in-terferon to treat chronic hepatitis C infection显示文摘Brok J Gluud LL Gluud C 2008Arch InternMed2008,165,:1
18Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy 显示文摘Holte K Krag A Gluud LL 2012Hepatol Res2012,42,10:1
19Fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis 显示文摘Krag A Wiest R Gluud LL 2010Am J Gastroenterol2010,105,6:1
20Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C:systematic review and metaanalysis of randomised controlled trials显示文摘Kimer N Dahl EK Gluud LL 0,,05:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费